ARCHIVES

Glaxo, Mass General Begin Phase III Trial Of Tykerb

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | December 29, 2006

Download PDF Visit The Full Archive

Related Articles

Pharmaceutical Industry: IVAX Official Broder Objects To Orphan Drug Policies of FDA

May 9, 1997

Combination Radiation/Vaccine May Benefit Some Patients

April 29, 2005

Young Molecular Biologists Optimistic, Survey Finds

February 21, 1997

Senate Calls Cancer Research a Priority, Cites Research Task Force Funding Goal

October 8, 1999

Medicare’s 21% Pay Cut In Effect Today; Congress Unlikely To Abandon SGR

June 18, 2010

No Cancer Letter For Two Weeks

August 10, 1990